Orit Rozenblatt-Rosen, PhD, is head of the Cell and Tissue Genomics Department and[KH2.1] co-leads foundational data for foundation models at Genentech. She also co-leads the Standards and Technology Working Group for the Human Cell Atlas. Dr. Rozenblatt-Rosen is a pioneer of single-cell genomics, especially in the context of human tissues. She is a strategic leader with extensive experience driving drug discovery and innovation at the intersection of genomics, biology, and AI. She is an expert in leveraging the “lab-in-the-loop” approach to identify novel targets, compounds, and biomarkers and is recognized for accelerating disease biology insights in oncology, neuroscience, and immunology through robust cross-functional collaboration.

‍

Prior to joining Genentech, Dr. Rozenblatt-Rosen held scientific appointments in academia over a 20-year period, first at the Dana-Farber Cancer Institute and then at the Broad Institute of MIT and Harvard. She received her BSc and MSc degrees from Tel Aviv University, and PhD from the Weizmann Institute of Science. She conducted postdoctoral studies at the Weizmann Institute of Science and the Dana-Farber Cancer Institute.